LoPriore Vincent S bought HEPA
September 3, 2026 · Form 4 insider transaction
LoPriore Vincent S bought 12,500,000 shares of Hepion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 11 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500,000
Price
$0.00
Total value
N/A
InsiderLoPriore Vincent S
Role—
SecurityWarrants
Transaction codeP: Open-market purchase
Transaction dateSeptember 3, 2026
Filing dateSeptember 14, 2026
Shares owned after22,500,000
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock.; Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.